Swiss Life Asset Management Ltd Acquires 6,730 Shares of Agilent Technologies, Inc. $A

Swiss Life Asset Management Ltd grew its position in Agilent Technologies, Inc. (NYSE:A) by 9.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 75,433 shares of the medical research company’s stock after buying an additional 6,730 shares during the period. Swiss Life Asset Management Ltd’s holdings in Agilent Technologies were worth $10,264,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of A. Massachusetts Financial Services Co. MA raised its holdings in Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after buying an additional 1,713,216 shares during the last quarter. AQR Capital Management LLC raised its holdings in Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after buying an additional 1,340,161 shares during the last quarter. SG Americas Securities LLC raised its holdings in Agilent Technologies by 3,091.1% in the fourth quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock worth $109,974,000 after buying an additional 782,888 shares during the last quarter. Finally, Lazard Asset Management LLC raised its holdings in Agilent Technologies by 639.4% in the second quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company’s stock worth $80,093,000 after buying an additional 586,931 shares during the last quarter.

Agilent Technologies Stock Performance

A opened at $112.93 on Wednesday. The stock has a market capitalization of $31.91 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 2.35 and a beta of 1.22. The company has a fifty day moving average of $115.46 and a 200 day moving average of $131.30. Agilent Technologies, Inc. has a fifty-two week low of $107.07 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Morgan Stanley decreased their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Barclays decreased their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. UBS Group decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. Finally, TD Cowen decreased their price objective on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.